Xumin Zhou

1.4k total citations · 1 hit paper
22 papers, 627 citations indexed

About

Xumin Zhou is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Xumin Zhou has authored 22 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Cancer Research. Recurrent topics in Xumin Zhou's work include RNA Research and Splicing (5 papers), Ferroptosis and cancer prognosis (4 papers) and RNA modifications and cancer (4 papers). Xumin Zhou is often cited by papers focused on RNA Research and Splicing (5 papers), Ferroptosis and cancer prognosis (4 papers) and RNA modifications and cancer (4 papers). Xumin Zhou collaborates with scholars based in China. Xumin Zhou's co-authors include Daojun Lv, Kaihui Wu, Taowei Yang, Junqi Luo, Wenbin Chen, Fangpeng Shu, Libin Zou, Xiangming Mao, Shengren Cen and Zining Long and has published in prestigious journals such as Cell Death and Disease, Oncotarget and Pharmacological Research.

In The Last Decade

Xumin Zhou

20 papers receiving 623 citations

Hit Papers

Gut dysbiosis promotes prostate cancer progression and do... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xumin Zhou China 14 403 286 186 105 62 22 627
Kai Fang China 14 572 1.4× 428 1.5× 91 0.5× 102 1.0× 66 1.1× 40 728
Qun Lv China 12 464 1.2× 213 0.7× 113 0.6× 49 0.5× 49 0.8× 25 685
Cui Li China 15 409 1.0× 311 1.1× 66 0.4× 70 0.7× 60 1.0× 47 657
Junhui Yu China 12 533 1.3× 127 0.4× 136 0.7× 98 0.9× 159 2.6× 25 685
Taohua Yue China 15 330 0.8× 174 0.6× 143 0.8× 144 1.4× 56 0.9× 24 607
Songping Xie China 15 349 0.9× 220 0.8× 90 0.5× 134 1.3× 90 1.5× 40 579

Countries citing papers authored by Xumin Zhou

Since Specialization
Citations

This map shows the geographic impact of Xumin Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xumin Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xumin Zhou more than expected).

Fields of papers citing papers by Xumin Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xumin Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xumin Zhou. The network helps show where Xumin Zhou may publish in the future.

Co-authorship network of co-authors of Xumin Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Xumin Zhou. A scholar is included among the top collaborators of Xumin Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xumin Zhou. Xumin Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jianlin, et al.. (2024). TIPARP as a prognostic biomarker and potential immunotherapeutic target in male papillary thyroid carcinoma. Cancer Cell International. 24(1). 34–34. 3 indexed citations
3.
Zhou, Xumin, Jiaqi Wang, Yufei Guo, et al.. (2024). Water extract of sporoderm-broken spores of Ganoderma lucidum elicits dual antitumor effects by inhibiting p-STAT3/PD-L1 and promoting ferroptosis in castration-resistant prostate cancer. Journal of Functional Foods. 113. 106018–106018. 2 indexed citations
4.
Luo, Junqi, Taowei Yang, Jun Wu, et al.. (2023). Exosomal PGAM1 promotes prostate cancer angiogenesis and metastasis by interacting with ACTG1. Cell Death and Disease. 14(8). 40 indexed citations
5.
Chen, Wenbin, Zhao Zhang, Shengren Cen, et al.. (2023). Exposure to elevated temperature affects the expression of PIWI‐interacting RNAs and associated transcripts in mouse testes. Andrology. 11(4). 724–737. 5 indexed citations
7.
Zou, Libin, Wenbin Chen, Xumin Zhou, et al.. (2022). N6-methyladenosine demethylase FTO suppressed prostate cancer progression by maintaining CLIC4 mRNA stability. Cell Death Discovery. 8(1). 184–184. 33 indexed citations
8.
Zhong, Weibo, Kaihui Wu, Zining Long, et al.. (2022). Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-κB-IL6-STAT3 axis. Microbiome. 10(1). 94–94. 132 indexed citations breakdown →
9.
Zhou, Xumin, Libin Zou, Hangyu Liao, et al.. (2021). Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+ T cell-mediated ferroptosis in castration-resistant prostate cancer. Acta Pharmaceutica Sinica B. 12(2). 692–707. 78 indexed citations
10.
Tan, Xiao, Wenbin Chen, Daojun Lv, et al.. (2021). LncRNA SNHG1 and RNA binding protein hnRNPL form a complex and coregulate CDH1 to boost the growth and metastasis of prostate cancer. Cell Death and Disease. 12(2). 138–138. 40 indexed citations
11.
Chen, Wenbin, Shengren Cen, Xumin Zhou, et al.. (2021). Circular RNA CircNOLC1, Upregulated by NF-KappaB, Promotes the Progression of Prostate Cancer via miR-647/PAQR4 Axis. Frontiers in Cell and Developmental Biology. 8. 624764–624764. 41 indexed citations
12.
Shu, Fangpeng, Taowei Yang, Xuefeng Zhang, et al.. (2021). Hyaluronic acid modified covalent organic polymers for efficient targeted and oxygen-evolved phototherapy. Journal of Nanobiotechnology. 19(1). 4–4. 20 indexed citations
13.
Zhou, Xumin, Libin Zou, Wenbin Chen, et al.. (2020). Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer. Pharmacological Research. 164. 105305–105305. 73 indexed citations
14.
Zhou, Xumin, Jinming Zhang, Xiao Hu, et al.. (2020). Pyrimethamine Elicits Antitumor Effects on Prostate Cancer by Inhibiting the p38-NF-κB Pathway. Frontiers in Pharmacology. 11. 758–758. 13 indexed citations
15.
Zhou, Xumin, Jinming Zhang, Jumei Liu, et al.. (2020). MicroRNA miR-155-5p knockdown attenuates Angiostrongylus cantonensis-induced eosinophilic meningitis by downregulating MMP9 and TSLP proteins. International Journal for Parasitology. 51(1). 13–22. 6 indexed citations
16.
Wu, Xiaoqiang, Shuo Wang, Xumin Zhou, et al.. (2020). Microstructures of the spermatic cord with three-dimensional reconstruction of sections of the cord and application to varicocele. Systems Biology in Reproductive Medicine. 66(3). 216–222. 3 indexed citations
17.
Zhou, Xumin, Jumei Liu, Jinming Zhang, Yong Wei, & Hua Li. (2018). Flubendazole inhibits glioma proliferation by G2/M cell cycle arrest and pro-apoptosis. Cell Death Discovery. 4(1). 18–18. 35 indexed citations
18.
Lv, Daojun, Huayan Wu, Fangpeng Shu, et al.. (2017). HnRNP-L mediates bladder cancer progression by inhibiting apoptotic signaling and enhancing MAPK signaling pathways. Oncotarget. 8(8). 13586–13599. 34 indexed citations
19.
Zhou, Xumin, Jincan He, Fangpeng Shu, et al.. (2016). HnRNP-L promotes prostate cancer progression by enhancing cell cycling and inhibiting apoptosis. Oncotarget. 8(12). 19342–19353. 28 indexed citations
20.
Shu, Fangpeng, Xumin Zhou, Fenxia Li, et al.. (2015). Analysis of the correlation of CATSPER single nucleotide polymorphisms (SNPs) with idiopathic asthenospermia. Journal of Assisted Reproduction and Genetics. 32(11). 1643–1649. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026